![Paolo Rampazzo](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ursprung des Netzwerks ersten Grades von Paolo Rampazzo
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
ExPharma Ltd.
![]() ExPharma Ltd. BiotechnologyHealth Technology ExPharma Ltd. is a virtual healthcare company. It specializes in food supplements, foods for special medical purposes, medical devices, and diagnostics. The company was founded on September 4, 2012 and is headquartered in London, the United Kingdom.
3
| Private Company | Biotechnology | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Paolo Rampazzo
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
CM&D Pharma Ltd.
![]() CM&D Pharma Ltd. Pharmaceuticals: MajorHealth Technology CM&D Pharma Ltd. provides pharmaceutical products. It is a specialty pharmacy company focused on foods for special medical purposes. Its products include Fostrap CKD, Recoclix, SilSOS, Eviendep, and Ossulin. The company was founded in 2007 and is headquartered in Surrey, UK. | Pharmaceuticals: Major | Founder Chief Tech/Sci/R&D Officer | |
University of Padua | College/University | Doctorate Degree Undergraduate Degree | |
Nemysis Ltd.
![]() Nemysis Ltd. BiotechnologyHealth Technology Nemysis Ltd. provides IP platform for medical treatments. It engages in the development of portfolio of IP protected, science-based compounds and products. The company was founded on October 21, 2005 and is headquartered in Dublin, Ireland. | Biotechnology | Chief Executive Officer Founder | |
Fidia Farmaceutici SpA
![]() Fidia Farmaceutici SpA Medical SpecialtiesHealth Technology Fidia Farmaceutici SpA manufactures pharmaceutical products. The firm's platform technology level is the chemical modification, development, and manufacturing of state-of-the-art pharmaceuticals and medical devices based on hyaluronan covering therapeutic categories. The company was founded in 1946 and is headquartered in Abano Terme, Italy. | Medical Specialties | Corporate Officer/Principal | |
Seventure Partners SA
![]() Seventure Partners SA Investment ManagersFinance Seventure Partners SA (Seventure) is a Venture Capital firm, a subsidiary of Natixis SA founded in 1997. Seventure Partners SA is headquartered in Paris. | Investment Managers | Investment Committee Member | |
TargEDys SA
![]() TargEDys SA BiotechnologyHealth Technology TargEDys SA develops microbiome-based solutions for appetite regulation. It provides humanity with easy means of regulating their eating behaviors for the third millennium. The company was founded by Pierre Dechelotte and Gregory Lambert 2011 and is headquartered in Paris, France. | Biotechnology | Director/Board Member | |
Prismic Pharmaceuticals, Inc.
![]() Prismic Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prismic Pharmaceuticals, Inc. engages in the research and development of prescription drugs for kidney disease, mental health, and chronic pain. It also offers medical foods for patients with chronic kidney disease, and depression and bipolar disorder. The company was founded by Zachary Dutton, Danilo Casadei Massari, and Peter J. Moriarty in 2011 and is headquartered in Worcester, MA. | Pharmaceuticals: Major | Founder | |
Ajinomoto Cambrooke, Inc.
![]() Ajinomoto Cambrooke, Inc. Pharmaceuticals: OtherHealth Technology Ajinomoto Cambrooke, Inc. operates as a therapeutic nutrition company. It offers Glytactin with GMP to help meet the nutritional needs of patients with Phenylketonuria; Tylactin with GMP to help meet the nutritional needs of patients with Tyrosinemia; amino acid formulas for the dietary management of disorders of amino acid metabolism; low protein food; KetoVie, ketogenic formulas for the dietary management of intractable epilepsy; and KetoVie Café Food low-carbohydrate ketogenic food for individuals following the spectrum of ketogenic diets. The company was founded by David Paolella and Lynn Paolella in 2000 and is headquartered in Ayer, MA. | Pharmaceuticals: Other | Director/Board Member | |
Glycemicon AG
![]() Glycemicon AG Miscellaneous Commercial ServicesCommercial Services Glycemicon AG develops novel nutraceuticals. The company was founded by Nadja Mrosek and Peter Harboe-Schmidt in 2013 and is headquartered in Brugg, Switzerland. | Miscellaneous Commercial Services | Director/Board Member | |
Opportunity Network Holdings Ltd.
![]() Opportunity Network Holdings Ltd. Internet Software/ServicesTechnology Services Opportunity Network Holdings Ltd. provides information technology services. The company was founded on March 30, 2015 and is headquartered in London, the United Kingdom. | Internet Software/Services | Director/Board Member |
Statistik
International
Vereinigtes Königreich | 4 |
Italien | 3 |
Frankreich | 3 |
Irland | 2 |
Kanada | 2 |
Sektoral
Health Technology | 8 |
Consumer Services | 2 |
Finance | 2 |
Commercial Services | 2 |
Technology Services | 2 |
Operativ
Director/Board Member | 10 |
Corporate Officer/Principal | 4 |
Founder | 4 |
Undergraduate Degree | 2 |
Chairman | 2 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Paolo Rampazzo
- Unternehmensverbindungen